Jaguar Health(JAGX) - 2024 Q1 - Earnings Call Transcript

And with that, I want to thank you all again. We're highly, highly energized about all the important near-term initiatives, including newly the upcoming launch of Gelclair and what is now imminent results from OnTarget for Cancer Therapy related Diarrhea Phase 3 Clinical Trial for Crofelemer. And this is a formulation that we currently have on the market Mytesi. Thank you all for the support of our mission to develop and commercialize prescription pharmaceuticals plant based for essential supportive care an ...